Search News

Corporate Industry Technology Medical Updates

pVAD

Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD 2024-05-14
Medical Updates
Percutaneous Ventricular Assist Device jointly developed by Ge Junbo’s team of Zhongshan Hospital affiliated to Fudan university and magAssist has made ground-breaking achievements 2021-07-17
Medical Updates
Zhongshan Hospital and magAssist Percutaneous Ventricular Assist Device Cooperation Kick-off Meeting Successfully Held 2020-09-07
Corporate
magAssist, Founding Member of “Suzhou-Soochow Overseas Chinese Entrepreneurship and Innovation Alliance”, Facilitates Innovation and Entrepreneurship of Returned Students 2023-01-16
Corporate
magAssist Wins Final of 11th China Innovation & Entrepreneurship Competition 2023-01-13
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device” 2023-01-06
Corporate
Highlights｜magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application 2022-12-12
Medical Updates
Percutaneous Ventricular Assist Device Led by Academician Junbo Ge and Jointly Developed by CCI and magAssist Makes Significant Progress 2021-11-11

Tabs： pVAD, cardiogenic shock, external life support systems, ECMO devices, IABP, Bridge-to-recovery, cardiogenic shock treatment, MoyoAssist Extra-VAD, solid technology of artificial hearts, Awards,